181 related articles for article (PubMed ID: 30243986)
21. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
22. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
[TBL] [Abstract][Full Text] [Related]
23. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
24. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis.
Yu J; Luo X; Xu H; Ma Q; Yuan J; Li X; Chang RC; Qu Z; Huang X; Zhuang Z; Liu J; Yang X
J Alzheimers Dis; 2015; 44(2):455-69. PubMed ID: 25352456
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
[TBL] [Abstract][Full Text] [Related]
26. Long-term naringin consumption reverses a glucose uptake defect and improves cognitive deficits in a mouse model of Alzheimer's disease.
Wang D; Gao K; Li X; Shen X; Zhang X; Ma C; Qin C; Zhang L
Pharmacol Biochem Behav; 2012 Jul; 102(1):13-20. PubMed ID: 22741174
[TBL] [Abstract][Full Text] [Related]
27. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss.
Ager RR; Davis JL; Agazaryan A; Benavente F; Poon WW; LaFerla FM; Blurton-Jones M
Hippocampus; 2015 Jul; 25(7):813-26. PubMed ID: 25530343
[TBL] [Abstract][Full Text] [Related]
28. Oligonol improves memory and cognition under an amyloid β(25-35)-induced Alzheimer's mouse model.
Choi YY; Maeda T; Fujii H; Yokozawa T; Kim HY; Cho EJ; Shibamoto T
Nutr Res; 2014 Jul; 34(7):595-603. PubMed ID: 25150118
[TBL] [Abstract][Full Text] [Related]
29. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
30. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice.
Dagher NN; Najafi AR; Kayala KM; Elmore MR; White TE; Medeiros R; West BL; Green KN
J Neuroinflammation; 2015 Aug; 12():139. PubMed ID: 26232154
[TBL] [Abstract][Full Text] [Related]
31. Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.
Nakamura N; Ohyagi Y; Imamura T; Yanagihara YT; Iinuma KM; Soejima N; Murai H; Yamasaki R; Kira JI
J Alzheimers Dis; 2017; 58(4):1151-1161. PubMed ID: 28550243
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
[TBL] [Abstract][Full Text] [Related]
33. Suppression of AIMP1 protects cognition in Alzheimer's disease model mice 3xTg-AD.
Jang S; Lee JH; Sohn BK; Kim E; Park SG; Yoon KJ; Park M; Kim EW; Jeong J; Lee JY; Kim CH; Namkoong K
Neuroreport; 2017 Jan; 28(2):82-86. PubMed ID: 27906773
[TBL] [Abstract][Full Text] [Related]
34. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease.
Luo J; Lee SH; VandeVrede L; Qin Z; Ben Aissa M; Larson J; Teich AF; Arancio O; D'Souza Y; Elharram A; Koster K; Tai LM; LaDu MJ; Bennett BM; Thatcher GR
Mol Neurodegener; 2016 Apr; 11():35. PubMed ID: 27129593
[TBL] [Abstract][Full Text] [Related]
35. Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model.
Dunn HC; Ager RR; Baglietto-Vargas D; Cheng D; Kitazawa M; Cribbs DH; Medeiros R
J Alzheimers Dis; 2015; 43(3):893-903. PubMed ID: 25125468
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes.
Sterniczuk R; Antle MC; Laferla FM; Dyck RH
Brain Res; 2010 Aug; 1348():149-55. PubMed ID: 20558146
[TBL] [Abstract][Full Text] [Related]
37. Enriched endogenous n-3 polyunsaturated fatty acids alleviate cognitive and behavioral deficits in a mice model of Alzheimer's disease.
Wu K; Gao X; Shi B; Chen S; Zhou X; Li Z; Gan Y; Cui L; Kang JX; Li W; Huang R
Neuroscience; 2016 Oct; 333():345-55. PubMed ID: 27474225
[TBL] [Abstract][Full Text] [Related]
38. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
39. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
[TBL] [Abstract][Full Text] [Related]
40. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S
Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
